Literature DB >> 11980866

Phenotypes of T cells infiltrating the eyes in autoimmune anterior uveitis associated with EAE.

Xingqi Zhang1, Shuguang Jiang, Maria Manczak, Brad Sugden, Grazyna Adamus.   

Abstract

PURPOSE: Lewis rats immunized with myelin basic protein (MBP) develop experimental autoimmune encephalomyelitis (EAE) and associated anterior uveitis (AU), which recurs. The goal was to analyze cellular activation markers and adhesion molecules of T cells that infiltrate the eyes and spinal cord during acute and recurrent AU in actively and passively induced diseases simultaneously in the same animals.
METHODS: EAE-AU was induced in Lewis rats by immunization with MBP in CFA, or by adoptive transfer of MBP-specific T-cell lines, and the signs of clinical EAE and AU was scored. Cells isolated from the iris-ciliary body were tested by flow cytometry for expression of CD4, CD8, CD45RC, T-cell receptor (TCR) Vbeta8.2, alpha4 integrin, L-selectin, CD44, and CD134.
RESULTS: Ocular T cells showed a significantly higher expression of CD62L (l-selectin) than did T cells in the spinal cord. In addition, a much lower percentage of infiltrating CD8(+) T cells was found in the eyes during AU. In passive transfer experiments, T-cell lines derived from acute and recurrent uveitis showing similar phenotypes differing in specificities but possessed the capacity of inducing both AU and EAE. Pretreatment of rats with effector CD4(+) T cell before MBP immunization did not induce suppression of EAE or AU. However, pretreatment with regulatory CD8(+) T cells significantly reduced the severity and duration of both EAE and AU.
CONCLUSIONS: T cells recruited into the inflamed eyes or central nervous system (CNS) are mainly activated/memory T cells expressing different levels of L-selectin. Regulatory CD8(+) T cells may contribute to the susceptibility of the eye to recurrent AU. The differences in phenotypes of T cells recruited simultaneously to two different organs suggest that microenvironment also plays a role in determining lymphocyte homing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11980866

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Genetic regulation of T regulatory, CD4, and CD8 cell numbers by the arthritis severity loci Cia5a, Cia5d, and the MHC/Cia1 in the rat.

Authors:  Max Brenner; Teresina Laragione; Nuriza C Yarlett; Pércio S Gulko
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

2.  Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection.

Authors:  Shalini Sharma; Naveen K Rajasagi; Tamara Veiga-Parga; Barry T Rouse
Journal:  Microbes Infect       Date:  2014-06-21       Impact factor: 2.700

3.  Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis.

Authors:  Pranita P Sarangi; Bumseok Kim; Barry T Rouse
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

4.  On the role of regulatory T cells during viral-induced inflammatory lesions.

Authors:  Tamara Veiga-Parga; Amol Suryawanshi; Sachin Mulik; Fernanda Giménez; Shalini Sharma; Tim Sparwasser; Barry T Rouse
Journal:  J Immunol       Date:  2012-11-05       Impact factor: 5.422

Review 5.  Visual Dysfunction in Multiple Sclerosis and its Animal Model, Experimental Autoimmune Encephalomyelitis: a Review.

Authors:  Taekyun Shin; Meejung Ahn; Jeongtae Kim; Kyungsook Jung; Changjong Moon; Moon-Doo Kim
Journal:  Mol Neurobiol       Date:  2021-03-20       Impact factor: 5.590

Review 6.  Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis.

Authors:  Yi-Hsing Chen; Sue Lightman; Malihe Eskandarpour; Virginia L Calder
Journal:  Int J Mol Sci       Date:  2022-01-03       Impact factor: 5.923

7.  Cancer-associated retinopathy in patients with breast carcinoma.

Authors:  Marta Misiuk-Hojło; Maria Ejma; Wojciech A Gorczyca; Stanisław Szymaniec; Danuta Witkowska; Wojciech Fortuna; Ryszard Miedzybrodzki; Jadwiga Rogozińska-Szczepka; Wiesława Bartnik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.